A phase 2 clinical trial testing the ability of BCG vaccine to reverse advanced type 1 diabetes has received approval from FDA.
The five year human trial will investigate whether BCG vaccination can clinically improve type 1 diabetes between 18 and 60 years of age who have small but still detectable levels of insulin secretion from pancreas,
In phase 1 clinical trials( published 2012 ) provided evidence of a small transient return of insulin secretion.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.